Xenia for Keratoconus

XENIA for keratoconus

Preventing corneal
transplantation
Stabilization and
vision improvement

XENIA implants are used to avoid corneal transplantation in patients with keratoconus or to defer corneal transplantation as long as possible.

The XENIA implant for keratoconus is crosslinked and therefore, significantly stronger as compared to the patient’s own stroma and thus stabilizes the patient cornea.

At the same time the XENIA implant regularizes the patient corneal topography. It flattens the cornea, as well as reduces Higher Order Aberrations (like for example Coma), and therefore, improves the patient’s visual acuity.

XENIA – the smart alternative to dalk

quick out-patient SURGERY
no sutures
rapid recovery
low risk procedure

For patients suffering from advanced keratoconus, DALK surgery (Deep Anterior Lamellar Keratoplasty) has been the surgical solution of choice in order to prevent corneal blindness. However, DALK surgery is very complex, involves general anaesthesia, requires corneal sutures and with any transplant surgery, there is always the risk of graft rejection.

The XENIA corneal implant for keratoconus is a substantially less complex, and minimally invasive alternative to a DALK transplant. Implanting XENIA is a standardized, straightforward and fast procedure. Simply insert the implant into a corneal pocket created by a Femto-Laser, no sutures required.

Requiring only topical anaesthesia, the surgery can be performed as an out-patient procedure.

XENIA is a sutureless procedure. Therefore, you eliminate all suture-related complications resulting in better vision, faster visual recovery and far fewer follow-up visits for patients.

The XENIA procedure reinforces and supports patient corneal tissue without a transplant which, therefore, thickens the cornea while avoiding all graft-related problems, like for example rejection, or downgrade from DALK to full Penetrating Keratoplasty (PK) due to (bubble-related) complications.

Using XENIA not only reduces all kinds of risks, it also offers flexibility because XENIA is reversible and a DALK could still be performed in a worst-case situation.

Finally, XENIA can be used in combination with Corneal Cross-Linking (CXL), because XENIA is increasing the corneal thickness, hence enabling CXL in patients with thinner corneas.

THE SURGICAL PROCEDURE FOR KERATOCONUS

For keratoconus patients a corneal stromal pocket with a small opening is created.

The XENIA implant is inserted by means of an injector or forceps.

After insertion, the XENIA implant is unfolded in the pocket.

For keratoconus patients a corneal stromal pocket with a small opening is created.

The XENIA implant is inserted by means of an injector or forceps.

After insertion, the XENIA implant is unfolded in the pocket.

SURGEON EXPERIENCES WITH XENIA

“The XENIA Lenticule is a ground-breaking treatment which can help Keratoconus and Post Lasik Ectasia patients. Early results have been very promising with very happy patients.”

Mr B Ilango MBBS DO FRCS FRCOphth Cert LRS
Group Medical Director: Optimax/Ultralase Clinics UK
Royal College Certified Laser & Multifocal Lens
Implant Specialist, Wolverhampton Eye Infirmary

“For me, the XENIA procedure has vast advantages over DALK. Implanting XENIA is so much easier because it is a quick, sutureless, out-patient procedure with no general anaesthesia. It provides my patients with superior corneal regularity, rapid visual rehabilitation and fewer follow-ups. Therefore, XENIA is an excellent alternative to performing DALK surgery in patients with advanced keratoconus.”

Ahmed Elmassry MD, PhD
Head of Ophthalmology Department
Professor of Ophthalmology
Alexandria University Egypt

“The XENIA Implant presents a fresh and novel approach towards keratoconus and post-ectasia treatment. The quick and effortless implantation procedure has allowed my keratoconus patients to live a life they couldn’t have possibly imagined before this intervention. In my opinion, the XENIA implant can serve as a platform for addressing wider vision issues beyond Keratoconus.”

Mr Marwan Ghabra, MD DO MRCOphth FRCS
Senior Consultant Ophthalmic Surgeon
Barts Health NHS Trust
Whipps Cross University Hospital
Leytonstone, London, UK

“XENIA Implant:
The beginning of a new treatment approach for corneal disease.”